Admissions at enrollment or < 24 hours (outpatients only) · patients with acute viral bronchiolitis
Epinephrine probably leads to lower admissions at enrollment or < 24 hours (outpatients only) compared with placebo (moderate certainty).
1 finding from 1 review
Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with steroid (moderate certainty).
1 finding from 1 review
Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with placebo (low certainty).
1 finding from 1 review
Length of stay (inpatients only) · patients with acute viral bronchiolitis
1 finding from 1 review
Admissions at enrollment or < 24 hours (outpatients only) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions at enrollment or < 24 hours (outpatients only) compared with salbutamol/albuterol (moderate certainty).
1 finding from 1 review
Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with salbutamol/albuterol (moderate certainty).
1 finding from 1 review
Length of stay (inpatients only) · patients with acute viral bronchiolitis
1 finding from 1 review
Admissions (outpatients) · patients with acute viral bronchiolitis
Epinephrine showed no clear difference in admissions (outpatients only) compared with steroid (moderate certainty).
1 finding from 1 review
Admissions at enrollment or < 24 hours (outpatients only) · patients with acute viral bronchiolitis
Epinephrine and steroid showed no clear difference in admissions at enrollment or < 24 hours (outpatients only) compared with placebo (low certainty).
1 finding from 1 review
Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis
Epinephrine and steroid may leads to lower admissions overall up to 7 days (outpatients only) compared with placebo (low certainty).
1 finding from 1 review
Time to recovery · children up to 12 months old with acute bronchiolitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · children up to 12 months old with acute bronchiolitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · children up to 12 months old with acute bronchiolitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · children up to 12 months old with acute bronchiolitis
It is very uncertain whether magnesium sulphate + epinephrine changes duration of hospital stay compared with no treatment or normal saline + epinephrine (very low certainty).
1 finding from 1 review
Clinical severity score (CSS) (RDAI score; range 0 to 17; higher = poorer outcomes) measured at 0 to 24 hoursafter treatment · children up to 12 months old with acute bronchiolitis
It is very uncertain whether magnesium sulphate + epinephrine changes clinical severity score (CSS) (RDAI score; range 0 to 17; higher =… compared with no treatment or normal saline + epinephrine (very low certainty).
1 finding from 1 review
Clinical severity score (CSS) (RDAI score; range 0 to 17; higher = poorer outcomes) measured 25 to 48 hoursafter treatment · children up to 12 months old with acute bronchiolitis
It is very uncertain whether magnesium sulphate + epinephrine changes clinical severity score (CSS) (RDAI score; range 0 to 17; higher =… compared with no treatment or normal saline + epinephrine (very low certainty).
1 finding from 1 review
Hospital re‐admission within 30 days of discharge · children up to 12 months old with acute bronchiolitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Admissions (outpatients) · children with acute bronchiolitis
2 findings from 1 review
Change in croup score. · children with croup
4 findings from 1 review
Show 1 more finding
Return visits or (re)admissions or both · children with croup
Any glucocorticoid showed no clear difference in return visits or (re)admissions or both compared with epinephrine (low certainty).
1 finding from 1 review